Conference Proceedings

Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2 BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy.

S Loi, B Haibe-Kains, DN Brown, J Metallo, LX Huan, C Desmedt, L Pusztai, M Piccart, FJ Esteva, C Sotiriou

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2010